Kiley Juergens Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Kiley Juergens Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $9,237 - $10,257	145 Added 1.38%	10,688 $683,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $692,780 - $785,769	10,543 New	10,543 $730,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $236,681 - $306,918	-4,854 Closed	0 $0
Q3 2018 Oct 10, 2018	SELL	$55.19 - $62.25 $3,311 - $3,735	-60 Reduced 1.22%	4,854 $301,000
Q2 2018 Jul 23, 2018	BUY	$50.53 - $62.98 $6,366 - $7,935	126 Added 2.63%	4,914 $271,000
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $11,624 - $13,382	-194 Reduced 3.89%	4,788 $302,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $298,621 - $325,573	4,982	4,982 $305,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.